Additionally, combination or multimodal therapy may provide greater efficacy compared to monotherapy in patients with OSA
[9] [10] These medications work by mimicking incretin hormones, enhancing glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety through central nervous system pathways
All plans below are sourced from Ozari's current treatment pricing
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed for type 2 diabetes treatment in the UK, administered subcutaneously once weekly
The National Institutes of Health provides a comprehensive evidence review
Since weight loss with these medications can happen quickly, you want to get ahead of any skin laxity before it really sets in